BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR-positive non small cell lung cancer patients: Results from a multicenter Italian observational study - Vavala, T; Follador, A; Tiseo, M (Lung Cancer, 2016)
et al.